Fairfield, Bush & Co’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-473
| Closed | -$17.5K | – | 253 |
|
|
2023
Q4 | $17.5K | Buy |
+473
| New | +$17.5K | 0.01% | 260 |
|
|
2023
Q3 | – | Sell |
-773
| Closed | -$27.6K | – | 264 |
|
|
2023
Q2 | $27.6K | Buy |
+773
| New | +$27.6K | 0.01% | 250 |
|
|
2022
Q3 | – | Sell |
-1,475
| Closed | -$80K | – | 248 |
|
|
2022
Q2 | $80K | Buy |
+1,475
| New | +$80K | 0.05% | 165 |
|
|
2016
Q4 | – | Sell |
-3,810
| Closed | -$205K | – | 149 |
|
|
2016
Q3 | $205K | Sell |
3,810
-480
| -11% | -$25.8K | 0.07% | 143 |
|
|
2016
Q2 | $232K | Sell |
4,290
-460
| -10% | -$24.9K | 0.08% | 123 |
|
|
2016
Q1 | $241K | Hold |
4,750
| – | – | 0.09% | 119 |
|
|
2015
Q4 | $240K | Sell |
4,750
-1,360
| -22% | -$68.7K | 0.08% | 131 |
|
|
2015
Q3 | $294K | Sell |
6,110
-400
| -6% | -$19.2K | 0.13% | 103 |
|
|
2015
Q2 | $339K | Hold |
6,510
| – | – | 0.1% | 130 |
|
|
2015
Q1 | $376K | Hold |
6,510
| – | – | 0.11% | 130 |
|
|
2014
Q4 | $348K | Hold |
6,510
| – | – | 0.1% | 131 |
|
|
2014
Q3 | $374K | Hold |
6,510
| – | – | 0.11% | 127 |
|
|
2014
Q2 | $435K | Buy |
6,510
+1,760
| +37% | +$118K | 0.13% | 114 |
|
|
2014
Q1 | $317K | Hold |
4,750
| – | – | 0.15% | 82 |
|
|
2013
Q4 | $317K | Hold |
4,750
| – | – | 0.14% | 85 |
|
|
2013
Q3 | $297K | Hold |
4,750
| – | – | 0.09% | 125 |
|
|
2013
Q2 | $297K | Buy |
+4,750
| New | +$297K | 0.15% | 109 |
|